 |
Previous Article | Next Article 
The Journal of Neuroscience, April 15, 2001, 21(8):2661-2668
DNA Replication Precedes Neuronal Cell Death in Alzheimer's
Disease
Yan
Yang1, 2,
David S.
Geldmacher1, 3, and
Karl
Herrup1, 2, 3
1 University Alzheimer Center, Departments of
2 Neuroscience and 3 Neurology, University
Hospitals of Cleveland and Case Western Reserve University School of
Medicine, Cleveland, Ohio 44106
 |
ABSTRACT |
Alzheimer's disease (AD) is a devastating dementia of late life
that is correlated with a region-specific neuronal cell loss. Despite
progress in uncovering many of the factors that contribute to the
etiology of the disease, the cause of the nerve cell death remains
unknown. One promising theory is that the neurons degenerate because
they reenter a lethal cell cycle. This theory receives support from
immunocytochemical evidence for the reexpression of several cell
cycle-related proteins. Direct proof for DNA replication, however, has
been lacking. We report here the use of fluorescent in
situ hybridization to examine the chromosomal complement of interphase neuronal nuclei in the adult human brain. We demonstrate that a significant fraction of the hippocampal pyramidal and basal forebrain neurons in AD have fully or partially replicated four separate genetic loci on three different chromosomes. Cells in unaffected regions of the AD brain or in the hippocampus of nondemented age-matched controls show no such anomalies. We conclude that the AD
neurons complete a nearly full S phase, but because mitosis is not
initiated, the cells remain tetraploid. Quantitative analysis indicates
that the genetic imbalance persists for many months before the cells
die, and we propose that this imbalance is the direct cause of the
neuronal loss in Alzheimer's disease.
Key words:
cell cycle; PCNA; cyclin B; hippocampus; nucleus basalis; FISH (fluorescent in situ hybridization); neurodegeneration
 |
INTRODUCTION |
The death of nerve cells during
early development is a constructive part of pruning and shaping the
emerging nervous system. The loss of neurons during adult life,
however, is a pathological process that produces behavioral disorders
and potentially the death of the organism. Recently, several
laboratories have offered evidence that an attempt by the cell to
reenter a mitotic cycle precedes many instances of neuronal death
(Smith and Lippa, 1995 ; Arendt et al., 1996 , 1998a ,b ; Vincent et al.,
1996 , 1997 , 1998 ; McShea et al., 1997 , 1999 ; Nagy et al., 1997a , 1998 ;
Busser et al., 1998 ; Smith et al., 1999 ). Together, these studies
suggest that the paradoxical association of the generative process of cell division with the degenerative process of cell death is found at
all stages of the existence of a neuron. The prohibition against cell
division begins at the earliest stages of maturation of a neuron.
Hindbrain neurons in mice lacking the retinoblastoma tumor suppressor gene are unable to avoid reentering the cell cycle and die
by apoptosis immediately after their emigration from the ventricular
zone (Lee et al., 1994 ). Neuronal cell death later in development has
also been linked to ectopic cell cycling. Using mutant models of
target-related cell death, Herrup and Busser (1995) showed that
target-deprived neurons initiated the synthesis of cell cycle enzymes
[cyclin D and proliferating cell nuclear antigen (PCNA)] and
incorporated bromodeoxyuridine (BrdU) into high molecular weight DNA
just before dying. During this same developmental period, if cell cycle
reentrance is forced by ectopically driving an oncogene with a
neuronal-specific promotor, the targeted neurons will die rather than
divide (al-Ubaidi et al., 1992 ; Feddersen et al., 1992 ). Several
in vitro cell death models have illustrated the same
correlation (Park et al., 1997 , 2000 ; Copani et al., 1999 ; Giovanni et
al., 1999 , 2000 ; Wu et al., 2000 ).
Of significant clinical relevance is the increasing evidence that
neuronal degeneration in the adult organism is also accompanied by
apparent cell cycle involvement. In both Alzheimer's disease (Smith
and Lippa, 1995 ; Arendt et al., 1996 , 1998a ,b ; Vincent et al.,
1996 , 1997 , 1998 ; McShea et al., 1997 , 1999 ; Nagy et al., 1997a , 1998 ;
Busser et al., 1998 ; Smith et al., 1999 ) and stroke (Hayashi et al.,
2000 ), cell cycle-related proteins appear in neurons at risk for death.
These observations suggest that the same prohibitions against cell
division that followed a neuron from the ventricular zone through the
developmental process remain in effect until the end of life. A
persistent question that accompanies this conclusion, however, is
whether the immunocytochemical appearance of cell cycle enzymes is
indicative of a true cell cycle or only the dysregulation of enzyme
synthesis. Direct proof of DNA replication has been missing in the
Alzheimer's disease brain. We report here the use of fluorescent
in situ hybridization (FISH) to examine human hippocampal
neurons in autopsy material from Alzheimer's disease patients and
controls. We find direct evidence for attempted cell cycling in the
Alzheimer's disease neurons and propose that the ultimate death of the
nerve cells is attributable to the genetic imbalance caused by the
tetraploid status of their genome.
This work describes original experiments that have not been published
previously in any venue except in abstract form (Yang et al.,
2000 ).
 |
MATERIALS AND METHODS |
FISH probes. Chromosome 11 probes were made from two
overlapping bacterial artificial chromosomes (BACs) obtained from
RPCI11 library (reference numbers 794I11 and 407N16). These probes come from the region of human chromosome 11 that encodes the -site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1), located at 11 (q23.3-q24.1). The centromeric
probes for chromosomes 18 and 21 were obtained from Oncor
(Gaithersburg, MD). The chromosome 18 probe was supplied with
biotin-substituted uridine residues, whereas the chromosome 21 probe
was supplied with digoxygenin-substituted residues. A second set of
probes for chromosome 21 was made from two overlapping
BACs (RPCI11 library, reference numbers 35J21 and
575G22) derived from the BACE2 locus (at 21q22.3). BAC
sequences were labeled by standard nick-translation protocols using
digoxygenin-labeled dUTP. After digoxygenin labeling, probes
were concentrated with human Cot-1 (Life Technologies) for at
least 2 hr to block repeat human sequences. The chromosomal
location of the various probes is illustrated in Figure 2.
Histology. Formalin-fixed brain autopsy tissue was obtained
from the Neuropathology Core of the University Hospitals/Case Western
Reserve University Alzheimer's Disease Research Center. After being
embedded in paraffin, 10 µm sections were cut and mounted on
Superfrost+ glass slides. The specifics of
each of the cases examined are detailed in Table 1. Cultured human
lymphocytes (line GM07038A) were received from the Human Genetics
service of University Hospitals/Case Western Reserve University. Cells
were grown in suspension for 70 hr, treated with colcemid (Life
Technologies; 10 µg/ml), grown for an additional 2 hr, then swelled
and lysed in hypotonic solution, fixed in methanol/acetic acid (3:1),
smeared onto glass slides, and dried.
For lymphocytes, the dried slides were transferred to 2× SSC for 60 min at 37°C, then dehydrated and air dried. The bound DNA was then
denatured in 70% formamide/2× SSC at 73°C for 2 min, after which
the sections were exposed to digoxygenin-substituted BACE1 probe and incubated overnight at 37°C. The probe
had been denatured previously at 73°C for 10 min and reannealed in
50% formamide/2× SSC hybridization buffer for at least 2 hr. Sites of
hybridization were revealed with mouse anti-digoxygenin antibody (Boehringer Mannheim, Indianapolis, IN) and an
Alexa-488-substituted goat anti-mouse IgG (Molecular Probes, Eugene, OR).
For the CNS tissue, sections were deparaffinized, pretreated with 30%
Pretreatment Powder (Oncor) for 15 min at 45°C, and then digested
with protease (Oncor; 0.25 mg/ml) for 25 min at 45°C. After rinsing,
slides were dehydrated through alcohols and allowed to air dry. Probe
was applied to the section, and a glass coverslip was overlaid to
prevent evaporation. Slides were heated to 90°C for 12 min to
denature the DNA and then incubated overnight at 37°C. Slides were
soaked in 50% formamide/2× SSC for 5 min to remove the coverslip;
then they were rinsed twice in the same buffer for 15 min at
37°C and once in 0.1× SSC for 30 min and transferred to phosphate
buffer at room temperature. Primary antibody was applied at a 1:100
dilution (in PBS with 1% normal goat serum) for 20 min at 37°C; then
the sections were rinsed three times in phosphate buffer. Secondary
antibody was applied at a 1:150 dilution, and the sections were
incubated for 20 min at 37°C. After rinsing, the sections were
counterstained with propidium iodide (1:40).
Quantitation. Sections were labeled as described above. For
each control and Alzheimer's disease case, 100 hippocampal cells were
examined in each of the four CA fields. A cell was counted only if the
equator of the nucleus was visible in the section. The number of spots
was determined at 1000× under fluorescent illumination. Counts of two
independent investigators (Y.Y. and K.H.) were comparable. Four control
and six Alzheimer's disease cases were counted, and the frequency of
cells with zero through four spots was tallied.
 |
RESULTS |
Examination of cresyl violet-stained sections of hippocampus and
basal forebrain from the Alzheimer's disease cases listed in Table
1 showed tissue atrophy and significant
cell loss (Fig. 1A-D).
As reported previously by several laboratories, including our own,
immunocytochemical staining for cell cycle enzymes revealed the
unexpected presence of cyclin B and PCNA in hippocampal neurons. Our
laboratory has also reported evidence of ectopic cell cycle proteins in
two other sites of known cell loss, the dorsal raphe and the locus
coeruleus (Busser et al., 1998 ). Another subcortical structure that is
recognized as suffering significant cell loss in Alzheimer's disease
is the basal nucleus of Meynert (Whitehouse et al., 1982 ), but this
region has not yet been examined for the presence of cell cycle
enzymes. Thus, as part of the present study, we have extended our
analysis to the at-risk neurons in this location. We found clear
evidence for the ectopic expression of the cell cycle proteins PCNA and
cyclin B in the large neurons of this structure (Fig.
1C,D). As described previously for hippocampus, dorsal raphe, and locus coeruleus, the fraction of the total neurons that were stained was small. This has been interpreted as a reflection that not all neurons are in the process of cell death at any one time.
Rather, only the dying neurons will express PCNA and cyclin B. The
location of the antigens was predominantly cytoplasmic, which is also
consistent with previous findings. During a normal cell cycle, both
PCNA and cyclin B are found in the nucleus, although both are known to
shuttle in and out of the cytoplasm at other times. The reason for
their predominantly cytoplasmic location in the Alzheimer's disease
brain is unknown.

View larger version (115K):
[in this window]
[in a new window]
|
Figure 1.
The appearance of the hippocampus and basal
nucleus in Alzheimer's disease. A, Loss of hippocampal
pyramidal cells is evident in this cresyl violet-stained field from AD
case 3 when compared with control (B). A similar
reduction in cell density is visible in the large neurons of the basal
nucleus of Meynert (C), compared with control
(D). Immunocytochemistry reveals presence of various
cell cycle-related proteins, including the DNA polymerase subunit, PCNA
(E), and the G2 cyclin, cyclin B
(F).
|
|
The expression of the cell cycle proteins is not, in and of itself,
direct evidence that a neuron has entered a formal cell cycle process.
Indeed, the unusual cytoplasmic location of the PCNA and cyclin B
proteins might be taken as evidence that some less organized
derepression of protein synthesis is at work. If this were an animal
model, we could approach the problem by supplying an exogenous DNA
precursor such as BrdU several hours before death (Herrup and
Busser, 1995 ). Even with this technique, however, questions could be
raised about the contribution of DNA repair to the observed labeling.
In any event, such an experimental approach in human patients with
Alzheimer's disease is precluded. We decided instead to look for
physical evidence of DNA replication by assessing the ploidy of the
neuronal genome at different chromosomal locations through the use of FISH.
The human genome consists of 22 pairs of autosomes plus two sex
chromosomes. Any unique DNA sequence should thus be represented twice,
but only twice, in every cell nucleus (except in known polyploid cells
such as liver hepatocytes). To approach the problem of DNA content in
brain neurons, we selected four large DNA sequences as probes. The
first probe consisted of overlapping BAC clones encompassing the
BACE1 locus on human chromosome 11 (Fig.
2). To assess the fidelity of our
technique, we hybridized this probe to a population of
colcemid-arrested human lymphocytes. After being derivatized with
digoxygenin-substituted nucleotides, the BACE1 probe was
applied to the cells, and its presence was revealed with an
anti-digoxygenin antibody. The results are shown in Figure 3. Most of the cells in our sample were
in interphase, and two spots of fluorescence were seen easily in the
nuclei of most of these cells (Fig. 3A). Mitotic figures
were also present, and because the BACE1 locus is near the
telomere of the long arm of chromosome 11 (q23.3-q24.1), labeling near
the end of a mid-sized chromosome was consistently found in metaphase
nuclei (Fig. 3B, arrows).

View larger version (11K):
[in this window]
[in a new window]
|
Figure 3.
Localization of FISH probes in cultured cells.
Pictured here is a metaphase spread of colcemid-blocked human
lymphocytes hybridized with the BACE1 BACs.
A, There are two spots (arrows) of
hybridization in most interphase cells. B, Note the
location of the specific hybridization (arrows) to the end
of a condensed chromosome 11 in metaphase cells. Scale bar, 10 µm.
|
|
We then adapted the FISH techniques to formalin-fixed paraffin-embedded
brain tissue. Distinct hybridization signals were found in all cell
types, including neurons, astrocytes, and microglial cells. Specific
hybridization was lost when excess unlabeled probe was added to the
hybridization mixture (data not shown). As expected, when we examined
control tissue sections from newborn cerebellum (Fig.
4A), 40-year-old
hippocampus (Fig. 4B), or age-matched controls for
the Alzheimer's disease cases (Figs. 4C), no neuronal
nucleus contained more than two spots of hybridization. Note that in
this and all subsequent Figures, small specks of background
fluorescence are visible. These are easily distinguished from the
specific locus of hybridization by their small size and reduced
luminosity. Tissue from Alzheimer's disease brain, however, produced a
significantly different picture. Hippocampal pyramidal cells from seven
pathologically verified cases of Alzheimer's disease were examined
(Table 1). Hybridization of the chromosome 11 probe in all seven cases
consistently revealed cells with three and four spots of hybridization
(Fig. 5A,B).
Such polyploid cells were found only in the Alzheimer's disease brain
and only in regions in which nerve cell death had been reported
previously. Samples from the same Alzheimer's brains, taken from
regions unaffected by disease pathology, showed no such anomalies.
Neurons in primary motor cortex (Fig. 5C) or cerebellum (Fig. 5D) showed two or fewer spots of bright fluorescence
per nucleus. Thus, a fraction of the cells in Ammon's horn of patients with Alzheimer's disease have replicated their genome in the region around the end of the long arm of chromosome 11.

View larger version (19K):
[in this window]
[in a new window]
|
Figure 4.
Normal diploid chromosomal complement is
found in most neurons at most ages. In each panel, arrows
indicate specific spots of hybridization. A,
BACE1 BAC hybridization to cerebellar granule cells of
newborn human cerebellum (propidium iodide counterstain). The high
density of cells in the internal granule cell layer results in the
apparent overlap of cells in these 10 µm paraffin sections.
B, BACE1 hybridization to hippocampal
pyramidal cells of a nondemented 40-year-old female. C,
Hippocampal neuron from area CA4 of a control case hybridized with the
BACE1 probe. Two or fewer spots of hybridization are seen.
The bright yellow/orange fluorescent material in
the cell cytoplasm is lipofuscin, which autofluoresces at the
wavelengths used. Note that in each of these control situations, we
find two or fewer spots of hybridization per cell. Scale bars, 10 µm.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
Figure 5.
FISH applied to neurons in affected areas of
Alzheimer's disease brain. A, Confocal image of a
hippocampal neuron from area CA3 of an Alzheimer's disease brain (case
9). Note the presence of four bright spots of fluorescence
(arrows) in the nucleus, suggesting a doubling of the
number of chromosomes 11 in this cell. B,
Hippocampal neuron from area CA4 of the same case (9). Three spots of
bright hybridization are found in this single nucleus, revealing
aneuploidy for this portion of chromosome 11. C, Neuron
from the motor cortex of the same Alzheimer's disease case (9)
hybridized with the same BACE1 probe. D,
Granule cells from the cerebellum of an Alzheimer's disease brain. In
these neurons, as in all others that we examined from this
region, two or fewer spots of hybridization (arrows) were
found. A was taken on a Zeiss confocal microscope.
B-D were taken at 1000× on a Leitz fluorescence
microscope. Scale bars: A, D, 10 µm.
|
|
To determine whether this apparent DNA replication was unique to
chromosome 11, we used a second set of overlapping BACs from the
BACE2 locus. Using identical protocols, we hybridized this probe to hippocampal sections from the same Alzheimer's disease cases.
As with the chromosome 11 probes, three and four spots of FISH
hybridization were found with this second probe in Alzheimer's disease
cases (Fig. 6A). The
BACE2 locus is near the end of the long arm of human
chromosome 21 (q22.3) (Fig. 2), and thus, at least two chromosomal loci
have replicated their DNA during the progression of the disease in
these individuals.

View larger version (20K):
[in this window]
[in a new window]
|
Figure 6.
Different probes from different chromosomes all
reveal aneuploidy in hippocampal neurons in Alzheimer's disease cases.
A, Hippocampal pyramidal cell from area CA4 of
Alzheimer's disease case 9 probed with the BACE2 probe. The
arrows indicate four spots of specific fluorescence
found in the nucleus. B, A cell from the same region of
the same case hybridized with the chromosome 21 centromeric probe.
Three spots of hybridization are clearly visible in the nucleus.
C, A CA3 hippocampal pyramidal neuron from control
brain. Two spots of hybridization (arrows) were
found when the same chromosome 21 centromeric probe was used. No cell
with more than two spots was found in this or any other control case.
D, A confocal image of a cell from Alzheimer's disease
case 9 hybridized with the probe to the centromere of chromosome 18. Note the three hybridization spots in the nucleus of this cell. Scale
bar, 10 µm.
|
|
During the cell cycle, DNA replication begins at origins of replication
in the arms of the chromosomes and ultimately involves the centromeric
regions (Nasmyth et al., 2000 ). To gain additional insight into whether
the entire genome had replicated, we used a probe specific to
centromeric satellite DNA of chromosome 21 (Fig. 2). This third probe
also revealed three and four spots in hippocampal neurons of
Alzheimer's disease tissue (Fig. 6B), but not in
age-matched control neurons (Fig. 6C). We obtained identical
results with a centromeric probe from chromosome 18; this probe too
revealed euploidy in control neurons and polyploidy in Alzheimer's
disease tissue (Fig. 6D).
The qualitative discovery of polyploidy in the at-risk neurons in
Alzheimer's disease is strong evidence that the cells have entered a
cell cycle that has proceeded through S phase. Because no neuron has
ever been observed in M phase, however, the cells must remain stalled
in a state resembling G2. To add quantitative detail to the qualitative picture, we performed cell counts of the FISH
preparations. Six of the Alzheimer's disease cases as well as four
controls were examined. A minimum of 400 hippocampal pyramidal neurons
were counted per case. In each of the Alzheimer's disease brains, but
in none of the controls, we found cells with three or four spots of
hybridization. When the results from counts using all four probes were
combined, the frequencies ranged from 0.005 to 0.100 of the total
number of cells, with a mean frequency of 0.037 ± 0.028 (SD)
(Table 2). As discussed below, these
values suggest that the cells remain in a tetraploid state for some
time before dying.
The observation of DNA replication is not unique to hippocampus. We
examined the large neurons of the basal nucleus of Meynert using both
the chromosome 11 and 21 BAC probes (Fig.
7). The results were nearly identical to
those from hippocampus. In basal forebrain neurons from patients with
Alzheimer's disease, we found consistent evidence for polyploidy,
whereas in control cases we were able to demonstrate more than two
spots of hybridization in only one case. The nucleus basalis has been
reported by others to show significant regional variation in atrophy,
and our cell cycle findings are consistent with these earlier results.
In every case, however, when immunocytochemistry revealed the presence
of ectopic cell cycle enzymes, FISH applied to adjacent sections
revealed evidence for polyploidy in a fraction of the neuronal nuclei. One feature of the hybridization that differed significantly between the hippocampal and basal nuclear neurons was the distribution of the
fluorescent spots. In hippocampus, the multiple spots tended to
distribute in an apparently random fashion throughout the nucleus (Figs. 5A, 6A). In the basal nucleus,
however, the four spots were most commonly seen as two doublets (Fig.
7, insets).

View larger version (10K):
[in this window]
[in a new window]
|
Figure 7.
Aneuploidy in the large neurons of the basal
nucleus of Meynert. A, B, Neurons
illustrated here were probed with either BACE1
(A) or BACE2 (B)
probes. In each case, examples of polyploid neurons were found in
Alzheimer's disease but not control brains. C, A
control brain probed with the BACE1 probe from chromosome
11. This field is typical of the results in the control cases in which
two or fewer spots of FISH hybridization (arrows) were
found. Scale bar, 10 µm.
|
|
 |
DISCUSSION |
We report here direct evidence in support of the hypothesis that
the neurons in the Alzheimer's disease brain reenter the cell cycle
before they die. The methodology we used to determine this, FISH, is
uniquely suited to assess cell cycle progression because it clearly
distinguishes DNA replication from other synthetic events such as DNA
repair. The observation that loci on three different chromosomes are
present in four copies rather than two suggests that in Alzheimer's
disease the entire genome of the neuron is duplicated before its death.
Our data show that the association of polyploid cells with the neurons
of an at-risk population is not restricted to hippocampal pyramidal
cells. The large catecholaminergic neurons of the basal nucleus of
Meynert have also undergone DNA replication. Although we have not yet applied FISH to the locus coeruleus or dorsal raphe, we have every reason to believe that earlier immunocytochemical findings in these
regions are also indicative of true cell cycle anomalies. Thus, entry
into an unscheduled cell cycle appears to precede the neuronal
loss in Alzheimer's disease, consistent with earlier immunocytochemical studies (Vincent et al., 1996 ; McShea et al., 1997 ;
Nagy et al., 1997a ; Arendt et al., 1998b ; Busser et al., 1998 ). Note,
however, that immunocytochemical demonstration of cell cycle enzyme
expression does not provide such unambiguous evidence for a concerted
cell division process in a normally postmitotic neuron.
Full DNA replication means that both the G1 and S
phases have been completed. The presence of cyclin B (a
G2 cyclin) suggests that the cycle has proceeded
into G2 and that there is a block in the cell
cycle at some point before M phase. The nature of this block is
unknown, but it has been shown that the cdc2/cyclin B complex is
present and active in Alzheimer's disease brain tissue (Vincent et
al., 1996 , 1997 ). Active cdc2 is a mitosis-promoting factor capable of
driving cells in culture into the series of elaborate chromosomal
movements required for M phase of the cell cycle. The presence of this
activity, along with evidence for a completed S phase, raises the
question of what factor or factors are missing in the adult neurons
that block their resolution of the cell cycle process.
This question is of particular interest, given the spatial distribution
of the spots of hybridization in our samples. In hippocampus, the spots
are scattered throughout the cell, as illustrated in Figures 5 and 6.
This distribution suggests that proteins such as the cohesin complexes
that normally hold replicated daughter chromosomes together (for
review, see Nasmyth et al., 2000 ) must either be degraded or perhaps
never synthesized. By contrast, in the basal nucleus, the four
hybridization signals almost always appear as two pairs of spots (Fig.
7). This picture is more consistent with a cell in which a well
regulated division process is halted at a normal
G2 cell cycle checkpoint. The genome content is
4n rather than 2n, yet the cell has maintained the pairing of the newly
replicated sister chromatids in anticipation of chromosome condensation. Indeed, the picture in hippocampus closely resembles that
found in a cell in which the cycle has processed to anaphase when the
SCC1 cohesin subunits are cleaved, allowing centromere separation
(Waizenegger et al., 2000 ). There has been no chromosome condensation,
however, and the suggestion is that the genetic material of the
pyramidal cells is in substantial disarray. The reason for this
regional difference is unclear, as are its consequences.
The details of our findings have important implications for the
mechanics of the neuronal cell death process in Alzheimer's disease.
Our quantitative analysis suggests that nearly 4% of the at-risk
neurons are in a polyploid state in the hippocampus of affected
individuals. Because our FISH sampling represents a "snapshot" of a
single moment in time, this value is unexpectedly large. Indeed, 4% is
likely to be an underestimate of the true number of polyploid neurons
because, as indicated by the 0 spot column in Table 2, the efficiency
of hybridization is not 100%. A simple calculation demonstrates the
significance of this value. In the developing mouse cerebellum, most
neurons die within 20 hr after entering the cell cycle (Herrup and
Busser, 1995 ) and thus would be visibly labeled with cell cycle markers
for only that short amount of time. Given that the time course of
Alzheimer's disease is roughly 10 years from diagnosis to death, and
if the same rate of cell death were applied, then the fraction of
neurons visibly present in a cell cycle would be (the
number of hours in 10 years) or . On the basis of
these simple assumptions, our observed rates suggest that the polyploid
neurons must survive for hundreds of days after their genome has
replicated. We therefore propose that the tetraploidy of the cells is
itself lethal and represents the fundamental cause of the demise of the
cells. The slow loss of synapses and atrophy of neuritic processes is
viewed in this model as a consequence of the persistent abnormal gene
dose. Recently Stadelmann et al. (1999) reported finding evidence for
the apoptotic demise of the Alzheimer's disease neurons. Their
observed fraction of caspase-3-positive cells ( to
) is close to the rate calculated above and
suggests that this process represents the final rapid demise of the
polyploid neurons.
This is only the second reported application of FISH techniques to
cells of the human adult CNS and the first using paraffin-embedded histological material. One previous report has appeared (Sendera et
al., 2000 ) in which FISH was used on fresh frozen cerebellar tissue to
demonstrate trisomy for chromosome 21 in a suspected case of Down's
syndrome. From a technicalstandpoint, it is noteworthy that our
material was obtained from conventional brain autopsy tissue that had
been formalin-fixed in the standard manner and received no other
special treatment. Thus, the approach we have adopted will be widely
useful in exploring somatic mosaicism of genetic content.
Aneuploidies such as trisomy 21 are devastating conditions leading to
severe mental retardation. When the nondisjunction event occurs after
gametogenesis, however, the condition can be much milder. Through the
application of FISH, the extent of mosaicism can be retrospectively
determined on a region by region basis using normally acquired
pathology samples of brain tissue. The correlation of the degree of
mosaicism in different areas with the clinical description of mental
function may help provide insight into the mechanisms of action of
different chromosomal aneuploidies. This analysis would proceed in much
the same the way that chimeras in chick and mouse have been used to
discover the sites of action of various genetic mutations.
It should be noted that the existence of chromosomal imbalance in
Alzheimer's disease has been proposed previously (Potter, 1991 ) on the
basis of the location of the APP gene on chromosome 21 (Kang et al.,
1987 ; Tanzi et al., 1987 ) and the early onset of Alzheimer's
disease-like pathology in the brains of patients with Down's
syndrome (trisomy 21). In support of this hypothesis, abnormal
segregation of chromosomes has been reported in fibroblast cells
bearing certain presenilin-1 mutations (Li et al., 1997 ; Geller and
Potter, 1999 ). Our results suggest that the extent of chromosomal
imbalance in Alzheimer's disease does exist, but it represents full
DNA replication rather than a specific nondisjunction-induced trisomy
of chromosome 21.
In Alzheimer's disease as well as in experimental animals, attempting
cell division in a mature neuron appears to be a lethal effort
(al-Ubaidi et al., 1992 ; Feddersen et al., 1992 ; Jacks et al., 1992 ;
Lee et al., 1992 ; Herrup and Busser, 1995 ). The source of the signal
that drives the neurons in Alzheimer's disease to begin the process
thus becomes a question of utmost importance. The -amyloid peptide
itself has been shown to be capable of driving cell division and cell
death in cultured neurons (Copani et al., 1999 ); in a similar assay,
conditioned medium from -amyloid-stimulated microglial cells can
also trigger neuronal cell division leading to cell death (Giovanni et
al., 1999 ; Wu et al., 2000 ). These latter data are particularly
intriguing given the epidemiological findings of a protective effect of
high doses of nonsteroidal anti-inflammatory drugs (P. McGeer and
McGeer, 1995 ; E. G. McGeer and McGeer, 1997 ). Thus, the
inflammatory process may be one source of the mitotic "pressure" in
Alzheimer's disease brain. Whatever the cause, however, the finding
that unscheduled reentrance into the cell cycle is the likely cause of
the neuronal degeneration in Alzheimer's disease opens various new
therapeutic avenues.
 |
FOOTNOTES |
Received Nov. 29, 2000; revised Jan. 10, 2001; accepted Jan. 24, 2001.
This work was supported by the National Institute on Aging through
Alzheimer's Disease Research Center Grant AG08120 and by National
Institutes of Neurological Diseases and Stroke Grant NS20591 to K.H. It
was also made possible by a generous grant from the Blanchette Hooker
Rockefeller Foundation.
Correspondence should be addressed to Karl Herrup, Alzheimer Research
Laboratory, Department of Neuroscience, Case Western Reserve
University, School of Medicine, 10900 Euclid Avenue, Cleveland, OH 44106. E-mail: kxh26{at}po.cwru.edu.
 |
REFERENCES |
-
al-Ubaidi MR,
Hollyfield JG,
Overbeek PA,
Baehr W
(1992)
Photoreceptor degeneration induced by the expression of simian virus 40 large tumor antigen in the retina of transgenic mice.
Proc Natl Acad Sci USA
89:1194-1198[Abstract/Free Full Text].
-
Arendt T,
Rodel L,
Gartner U,
Holzer M
(1996)
Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease.
NeuroReport
7:3047-3049[Web of Science][Medline].
-
Arendt T,
Holzer M,
Gartner U
(1998a)
Neuronal expression of cyclin dependent kinase inhibitors of the INK4 family in Alzheimer's disease.
J Neural Transm
105:949-960.
-
Arendt T,
Holzer M,
Gartner U,
Bruckner MK
(1998b)
Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease.
J Neural Transm [Suppl]
54:147-158[Medline].
-
Busser J,
Geldmacher DS,
Herrup K
(1998)
Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain.
J Neurosci
18:2801-2807[Abstract/Free Full Text].
-
Copani A,
Condorelli F,
Caruso A,
Vancheri C,
Sala A,
Giuffrida Stella AM,
Canonico PL,
Nicoletti F,
Sortino MA
(1999)
Mitotic signaling by beta-amyloid causes neuronal death.
FASEB J
13:2225-2234[Abstract/Free Full Text].
-
Feddersen RM,
Ehlenfeldt R,
Yunis WS,
Clark HB,
Orr HT
(1992)
Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice.
Neuron
9:955-966[Web of Science][Medline].
-
Geller LN,
Potter H
(1999)
Chromosome missegregation and trisomy 21 mosaicism in Alzheimer's disease.
Neurobiol Dis
6:167-179[Web of Science][Medline].
-
Giovanni A,
Wirtz-Brugger F,
Keramaris E,
Slack R,
Park DS
(1999)
Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in B-amyloid-induced neuronal death.
J Biol Chem
274:19011-19016[Abstract/Free Full Text].
-
Giovanni A,
Keramaris E,
Morris EJ,
Hou ST,
O'Hare M,
Dyson N,
Robertson GS,
Slack RS,
Park DS
(2000)
E2F1 mediates death of
-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3.
J Biol Chem
275:11553-11560[Abstract/Free Full Text]. -
Hayashi T,
Sakai K,
Sasaki C,
Zhang WR,
Abe K
(2000)
Phosphorylation of retinoblastoma protein in rat brain after transient middle cerebral artery occlusion.
Neuropathol Appl Neurobiol
26:390-397[Web of Science][Medline].
-
Herrup K,
Busser JC
(1995)
The induction of multiple cell cycle events precedes target-related neuronal death.
Development
121:2385-2395[Abstract].
-
Jacks T,
Fazeli A,
Schmitt E,
Bronson R,
Goodell M,
Weinberg R
(1992)
Effects of an Rb mutation in the mouse.
Nature
359:295-300[Medline].
-
Kang J,
Lemaire HG,
Unterbeck A,
Salbaum JM,
Masters CL,
Grzeschik KH,
Multhaup G,
Beyreuther K,
Muller-Hill B
(1987)
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.
Nature
325:733-736[Medline].
-
Lee E-H,
Hu N,
Yuan SS,
Cox LA,
Bradley A,
Lee WH,
Herrup K
(1994)
Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation.
Genes Dev
8:2008-2021[Abstract/Free Full Text].
-
Lee EY-HP,
Chang C-Y,
Hu N,
Wang Y-CJ,
Lai C-C,
Herrup K,
Lee W-H,
Bradley A
(1992)
Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis.
Nature
359:288-294[Medline].
-
Li J,
Xu M,
Zhou H,
Ma J,
Potter H
(1997)
Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation.
Cell
90:917-927[Web of Science][Medline].
-
McGeer EG,
McGeer PL
(1997)
The role of the immune system in neurodegenerative disorders.
Mov Disord
12:855-858[Web of Science][Medline].
-
McGeer P,
McGeer E
(1995)
The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases.
Brain Res Rev
21:195-218[Medline].
-
McShea A,
Harris PL,
Webster KR,
Wahl AF,
Smith MA
(1997)
Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.
Am J Pathol
150:1933-1939[Abstract].
-
McShea A,
Wahl AF,
Smith MA
(1999)
Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease.
Med Hypotheses
52:525-527[Web of Science][Medline].
-
Nagy Z,
Esiri MM,
Smith AD
(1997a)
Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions.
Acta Neuropathol (Berl)
93:294-300[Medline].
-
Nagy Z,
Esiri MM,
Cato AM,
Smith AD
(1997b)
Cell cycle markers in the hippocampus in Alzheimer's disease.
Acta Neuropathol (Berl)
94:6-15[Medline].
-
Nagy Z,
Esiri MM,
Smith AD
(1998)
The cell division cycle and the pathophysiology of Alzheimer's disease.
Neuroscience
87:731-739[Web of Science][Medline].
-
Nasmyth K,
Peters J-M,
Uhlmann F
(2000)
Splitting the chromosome: cutting the ties that bind sister chromatids.
Science
288:1379-1384[Abstract/Free Full Text].
-
Park DS,
Morris EJ,
Greene LA,
Geller HM
(1997)
G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis.
J Neurosci
17:1256-1270[Abstract/Free Full Text].
-
Park DS,
Morris EJ,
Bremner R,
Keramaris E,
Padmanabhan J,
Rosenbaum M,
Shelanski ML,
Geller HM,
Greene LA
(2000)
Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage.
J Neurosci
20:3104-3114[Abstract/Free Full Text].
-
Potter H
(1991)
Review and hypothesis: Alzheimer disease and Down syndrome-chromosome 21 nondisjunction may underlie both disorders.
Am J Hum Genet
48:1192-1200[Web of Science][Medline].
-
Sendera TJ,
Ma SY,
Jaffar S,
Kozlowski PB,
Kordower JH,
Mawal Y,
Saragovi HU,
Mufson EJ
(2000)
Reduction in TrkA-immunoreactive neurons is not associated with an overexpression of galaninergic fibers within the nucleus basalis in Down's syndrome.
J Neurochem
74:1185-1196[Web of Science][Medline].
-
Smith MZ,
Nagy Z,
Esiri MM
(1999)
Cell cycle-related protein expression in vascular dementia and Alzheimer's disease.
Neurosci Lett
271:45-48[Web of Science][Medline].
-
Smith TW,
Lippa CF
(1995)
Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders.
J Neuropathol Exp Neurol
54:297-303[Web of Science][Medline].
-
Stadelmann C,
Deckwerth T,
Srinivasan A,
Bancher C,
Brück W,
Jellinger K,
Lassmann H
(1999)
Activation of caspase-3 in single neurons and autophagic granules of granulovacular degeneration in Alzheimer's disease: evidence for apoptotic cell death.
Am J Pathol
155:1459-1466[Abstract/Free Full Text].
-
Tanzi RE,
Gusella JF,
Watkins PC,
Bruns GA,
St. George-Hyslop P,
Van Keuren ML,
Patterson D,
Pagan S,
Kurnit DM,
Neve RL
(1987)
Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.
Science
235:880-884[Abstract/Free Full Text].
-
Vincent I,
Rosado M,
Davies P
(1996)
Mitotic mechanisms in Alzheimer's disease?
J Cell Biol
132:413-425[Abstract/Free Full Text].
-
Vincent I,
Jicha G,
Rosado M,
Dickson D
(1997)
Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.
J Neurosci
17:3588-3598[Abstract/Free Full Text].
-
Vincent I,
Zheng JH,
Dickson DW,
Kress Y,
Davies P
(1998)
Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease.
Neurobiol Aging
19:287-296[Web of Science][Medline].
-
Waizenegger IC,
Hauf S,
Meinke A,
Peters JM
(2000)
Two distinct pathways remove mammalian cohesin from chromosome arms in prophase and from centromeres in anaphase.
Cell
103:399-410[Web of Science][Medline].
-
Whitehouse P,
Price D,
Struble R,
Clark A,
Coyle J,
DeLong M
(1982)
Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.
Science
215:1237-1239[Abstract/Free Full Text].
-
Wu Q,
Combs C,
Cannady S,
Geldmacher D,
Herrup K
(2000)
Beta-amyloid activated microglia induce cell cycling and cell death in cultured cortical neurons.
Neurobiol Aging
21:797-806[Web of Science][Medline].
-
Yang Y,
Cicero SA,
Geldmacher DS,
Herrup K
(2000)
DNA replication occurs in at-risk neurons in the Alzheimer's disease brain.
Soc Neurosci Abstr
26:1550.
Copyright © 2001 Society for Neuroscience 0270-6474/01/2182661-08$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
R. A. Poche and B. E. Reese
Retinal horizontal cells: challenging paradigms of neural development and cancer biology
Development,
July 1, 2009;
136(13):
2141 - 2151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Martin, Z. Liu, J. Pipino, B. Chestnut, and M. A. Landek
Molecular Regulation of DNA Damage-Induced Apoptosis in Neurons of Cerebral Cortex
Cereb Cortex,
June 1, 2009;
19(6):
1273 - 1293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. He and Y. Shen
Interruption of {beta}-Catenin Signaling Reduces Neurogenesis in Alzheimer's Disease
J. Neurosci.,
May 20, 2009;
29(20):
6545 - 6557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-g. Lee, G. Casadesus, A. Nunomura, X. Zhu, R. J. Castellani, S. L. Richardson, G. Perry, D. W. Felsher, R. B. Petersen, and M. A. Smith
The Neuronal Expression of MYC Causes a Neurodegenerative Phenotype in a Novel Transgenic Mouse
Am. J. Pathol.,
March 1, 2009;
174(3):
891 - 897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-P. Ge, W. Zhou, Q. Luo, L. Y. Jan, and Y. N. Jan
Dividing glial cells maintain differentiated properties including complex morphology and functional synapses
PNAS,
January 6, 2009;
106(1):
328 - 333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. H. Varvel, K. Bhaskar, A. R. Patil, S. W. Pimplikar, K. Herrup, and B. T. Lamb
A{beta} Oligomers Induce Neuronal Cell Cycle Events in Alzheimer's Disease
J. Neurosci.,
October 22, 2008;
28(43):
10786 - 10793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhang, S. A. Cicero, L. Wang, R. R. Romito-DiGiacomo, Y. Yang, and K. Herrup
Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons
PNAS,
June 24, 2008;
105(25):
8772 - 8777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Amit, Y. Avramovich-Tirosh, M. B. H. Youdim, and S. Mandel
Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators
FASEB J,
May 1, 2008;
22(5):
1296 - 1305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. G. Sala, U. Munoz, F. Bartolome, F. Bermejo, and A. Martin-Requero
HMG-CoA Reductase Inhibitor Simvastatin Inhibits Cell Cycle Progression at the G1/S Checkpoint in Immortalized Lymphocytes from Alzheimer's Disease Patients Independently of Cholesterol-Lowering Effects
J. Pharmacol. Exp. Ther.,
January 1, 2008;
324(1):
352 - 359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wang, R. Wang, and K. Herrup
E2F1 Works as a Cell Cycle Suppressor in Mature Neurons
J. Neurosci.,
November 14, 2007;
27(46):
12555 - 12564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Mosch, M. Morawski, A. Mittag, D. Lenz, A. Tarnok, and T. Arendt
Aneuploidy and DNA Replication in the Normal Human Brain and Alzheimer's Disease
J. Neurosci.,
June 27, 2007;
27(26):
6859 - 6867.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nizzari, V. Venezia, E. Repetto, V. Caorsi, R. Magrassi, M. C. Gagliani, P. Carlo, T. Florio, G. Schettini, C. Tacchetti, et al.
Amyloid Precursor Protein and Presenilin1 Interact with the Adaptor GRB2 and Modulate ERK 1,2 Signaling
J. Biol. Chem.,
May 4, 2007;
282(18):
13833 - 13844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Friedel, G. Kerjan, H. Rayburn, U. Schuller, C. Sotelo, M. Tessier-Lavigne, and A. Chedotal
Plexin-B2 Controls the Development of Cerebellar Granule Cells
J. Neurosci.,
April 4, 2007;
27(14):
3921 - 3932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. H. J. Park, J. L. Hallows, P. Chakrabarty, P. Davies, and I. Vincent
Conditional Neuronal Simian Virus 40 T Antigen Expression Induces Alzheimer-Like Tau and Amyloid Pathology in Mice
J. Neurosci.,
March 14, 2007;
27(11):
2969 - 2978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. U. Hoglinger, J. J. Breunig, C. Depboylu, C. Rouaux, P. P. Michel, D. Alvarez-Fischer, A.-L. Boutillier, J. DeGregori, W. H. Oertel, P. Rakic, et al.
The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease
PNAS,
February 27, 2007;
104(9):
3585 - 3590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Macas, C. Nern, K. H. Plate, and S. Momma
Increased Generation of Neuronal Progenitors after Ischemic Injury in the Aged Adult Human Forebrain
J. Neurosci.,
December 13, 2006;
26(50):
13114 - 13119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Ackman, F. Siddiqi, R. S. Walikonis, and J. J. LoTurco
Fusion of microglia with pyramidal neurons after retroviral infection.
J. Neurosci.,
November 1, 2006;
26(44):
11413 - 11422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Copani, J. J. M. Hoozemans, F. Caraci, M. Calafiore, E. S. Van Haastert, R. Veerhuis, A. J. M. Rozemuller, E. Aronica, M. A. Sortino, and F. Nicoletti
DNA Polymerase-beta Is Expressed Early in Neurons of Alzheimer's Disease Brain and Is Loaded into DNA Replication Forks in Neurons Challenged with beta-Amyloid
J. Neurosci.,
October 25, 2006;
26(43):
10949 - 10957.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yang, N. H. Varvel, B. T. Lamb, and K. Herrup
Ectopic Cell Cycle Events Link Human Alzheimer's Disease and Amyloid Precursor Protein Transgenic Mouse Models
J. Neurosci.,
January 18, 2006;
26(3):
775 - 784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D'Ambrosio, S. Arena, G. Fulcoli, M. H. Scheinfeld, D. Zhou, L. D'Adamio, and A. Scaloni
Hyperphosphorylation of JNK-interacting Protein 1, a Protein Associated with Alzheimer Disease
Mol. Cell. Proteomics,
January 1, 2006;
5(1):
97 - 113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bauer and P. H. Patterson
The cell cycle-apoptosis connection revisited in the adult brain
J. Cell Biol.,
November 21, 2005;
171(4):
641 - 650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Andorfer, C. M. Acker, Y. Kress, P. R. Hof, K. Duff, and P. Davies
Cell-Cycle Reentry and Cell Death in Transgenic Mice Expressing Nonmutant Human Tau Isoforms
J. Neurosci.,
June 1, 2005;
25(22):
5446 - 5454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Kingsbury, B. Friedman, M. J. McConnell, S. K. Rehen, A. H. Yang, D. Kaushal, and J. Chun
Aneuploid neurons are functionally active and integrated into brain circuitry
PNAS,
April 26, 2005;
102(17):
6143 - 6147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yang and K. Herrup
Loss of Neuronal Cell Cycle Control in Ataxia-Telangiectasia: A Unified Disease Mechanism
J. Neurosci.,
March 9, 2005;
25(10):
2522 - 2529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Rehen, Y. C. Yung, M. P. McCreight, D. Kaushal, A. H. Yang, B. S. V. Almeida, M. A. Kingsbury, K. M. S. Cabral, M. J. McConnell, B. Anliker, et al.
Constitutional Aneuploidy in the Normal Human Brain
J. Neurosci.,
March 2, 2005;
25(9):
2176 - 2180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. B. Yurov, I. Y. Iourov, V. V. Monakhov, I. V. Soloviev, V. M. Vostrikov, and S. G. Vorsanova
The Variation of Aneuploidy Frequency in the Developing and Adult Human Brain Revealed by an Interphase FISH Study
J. Histochem. Cytochem.,
March 1, 2005;
53(3):
385 - 390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-Y. Kuan, A. J. Schloemer, A. Lu, K. A. Burns, W.-L. Weng, M. T. Williams, K. I. Strauss, C. V. Vorhees, R. A. Flavell, R. J. Davis, et al.
Hypoxia-Ischemia Induces DNA Synthesis without Cell Proliferation in Dying Neurons in Adult Rodent Brain
J. Neurosci.,
November 24, 2004;
24(47):
10763 - 10772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Herrup, R. Neve, S. L. Ackerman, and A. Copani
Divide and Die: Cell Cycle Events as Triggers of Nerve Cell Death
J. Neurosci.,
October 20, 2004;
24(42):
9232 - 9239.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zhang, J. Li, P. Chakrabarty, B. Bu, and I. Vincent
Cyclin-Dependent Kinase Inhibitors Attenuate Protein Hyperphosphorylation, Cytoskeletal Lesion Formation, and Motor Defects in Niemann-Pick Type C Mice
Am. J. Pathol.,
September 1, 2004;
165(3):
843 - 853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. Gray, G. A. Petsko, G. C. Johnston, D. Ringe, R. A. Singer, and M. Werner-Washburne
"Sleeping Beauty": Quiescence in Saccharomyces cerevisiae
Microbiol. Mol. Biol. Rev.,
June 1, 2004;
68(2):
187 - 206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wen, S. Yang, R. Liu, A. M. Brun-Zinkernagel, P. Koulen, and J. W. Simpkins
Transient Cerebral Ischemia Induces Aberrant Neuronal Cell Cycle Re-entry and Alzheimer's Disease-like Tauopathy in Female Rats
J. Biol. Chem.,
May 21, 2004;
279(21):
22684 - 22692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Lee, R. Thangavel, V. M. Sharma, J. M. Litersky, K. Bhaskar, S. M. Fang, L. H. Do, A. Andreadis, G. Van Hoesen, and H. Ksiezak-Reding
Phosphorylation of Tau by Fyn: Implications for Alzheimer's Disease
J. Neurosci.,
March 3, 2004;
24(9):
2304 - 2312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Zeiss and E. A. Johnson
Proliferation of Microglia, but not Photoreceptors, in the Outer Nuclear Layer of the rd-1 Mouse
Invest. Ophthalmol. Vis. Sci.,
March 1, 2004;
45(3):
971 - 976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Verdaguer, A. Jimenez, A. M. Canudas, E. G. Jorda, F. X. Sureda, M. Pallas, and A. Camins
Inhibition of Cell Cycle Pathway by Flavopiridol Promotes Survival of Cerebellar Granule Cells after an Excitotoxic Treatment
J. Pharmacol. Exp. Ther.,
February 1, 2004;
308(2):
609 - 616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Harris, I. Tesseur, W. J. Brecht, Q. Xu, K. Mullendorff, S. Chang, T. Wyss-Coray, R. W. Mahley, and Y. Huang
Astroglial Regulation of Apolipoprotein E Expression in Neuronal Cells: IMPLICATIONS FOR ALZHEIMER'S DISEASE
J. Biol. Chem.,
January 30, 2004;
279(5):
3862 - 3868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chen, W. Liu, D. L. McPhie, L. Hassinger, and R. L. Neve
APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimer's disease brain
J. Cell Biol.,
October 13, 2003;
163(1):
27 - 33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. McPhie, R. Coopersmith, A. Hines-Peralta, Y. Chen, K. J. Ivins, S. P. Manly, M. R. Kozlowski, K. A. Neve, and R. L. Neve
DNA Synthesis and Neuronal Apoptosis Caused by Familial Alzheimer Disease Mutants of the Amyloid Precursor Protein Are Mediated by the p21 Activated Kinase PAK3
J. Neurosci.,
July 30, 2003;
23(17):
6914 - 6927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yang, E. J. Mufson, and K. Herrup
Neuronal Cell Death Is Preceded by Cell Cycle Events at All Stages of Alzheimer's Disease
J. Neurosci.,
April 1, 2003;
23(7):
2557 - 2563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Nguyen, M. Boudreau, J. Kriz, S. Couillard-Despres, D. R. Kaplan, and J.-P. Julien
Cell Cycle Regulators in the Neuronal Death Pathway of Amyotrophic Lateral Sclerosis Caused by Mutant Superoxide Dismutase 1
J. Neurosci.,
March 15, 2003;
23(6):
2131 - 2140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ranganathan and R. Bowser
Alterations in G1 to S Phase Cell-Cycle Regulators during Amyotrophic Lateral Sclerosis
Am. J. Pathol.,
March 1, 2003;
162(3):
823 - 835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Koketsu, A. Mikami, Y. Miyamoto, and T. Hisatsune
Nonrenewal of Neurons in the Cerebral Neocortex of Adult Macaque Monkeys
J. Neurosci.,
February 1, 2003;
23(3):
937 - 942.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Bamberger and G. E. Landreth
Inflammation, Apoptosis, and Alzheimer's Disease
Neuroscientist,
June 1, 2002;
8(3):
276 - 283.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Copani, D. Melchiorri, A. Caricasole, F. Martini, P. Sale, R. Carnevale, R. Gradini, M. A. Sortino, L. Lenti, R. De Maria, et al.
beta -Amyloid-Induced Synthesis of the Ganglioside Gd3 Is a Requisite for Cell Cycle Reactivation and Apoptosis in Neurons
J. Neurosci.,
May 15, 2002;
22(10):
3963 - 3968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. T. Nelson, D. Kondziolka, L. Wechsler, S. Goldstein, J. Gebel, S. DeCesare, E. M. Elder, P. J. Zhang, A. Jacobs, M. McGrogan, et al.
Clonal Human (hNT) Neuron Grafts for Stroke Therapy : Neuropathology in a Patient 27 Months after Implantation
Am. J. Pathol.,
April 1, 2002;
160(4):
1201 - 1206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. I. Kruman, T. S. Kumaravel, A. Lohani, W. A. Pedersen, R. G. Cutler, Y. Kruman, N. Haughey, J. Lee, M. Evans, and M. P. Mattson
Folic Acid Deficiency and Homocysteine Impair DNA Repair in Hippocampal Neurons and Sensitize Them to Amyloid Toxicity in Experimental Models of Alzheimer's Disease
J. Neurosci.,
March 1, 2002;
22(5):
1752 - 1762.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|